Yolo Swaggins

👽 Why SARS-CoV-2 Is So Uniquely Dangerous 👽 Key Takeaways: SARS-CoV-2 is not "a bad respiratory virus." It is a systemic pathogen whose molecular architecture - a furin cleavage site absent in its closest relatives, near-universal ACE2 tropism, a spike protein that is itself toxic, and the ability to linger in tissue reservoirs - lets it seed simultaneous damage across the vascular, neurological, metabolic, and immune systems. The result is a disease, and an aftermath, with no precedent among coronaviruses, betacoronaviruses, or non-retroviral, non-herpetic RNA viruses.

New paper: Long Covid exposes a blind spot in how governments define “security.” We mobilize for acute, visible crises, but normalize slow, mass disability - even as it erodes health systems, labor, economies, and social stability. Disability is still not treated as a crisis. link.springer.com/article/10…

📈 Cumulative Risk with each SARS2 Infection The dose–response: each infection adds risk The foundational evidence comes from Bowe, Xie & Al-Aly (2022), who studied 5.8 million people in the US Department of Veterans Affairs database. They found that compared with no reinfection, people with two, three, or more infections had progressively higher risks of death, hospitalization, and post-acute sequelae affecting the pulmonary, cardiovascular, hematological, diabetes, gastrointestinal, kidney, mental health, musculoskeletal, and neurological systems. The hazard ratio for developing at least one sequela climbed from 1.35 after the first infection to 2.11 after the second and 3.00 after three or more infections - a clear cumulative, dose-dependent pattern. A large matched cohort from the N3C Data Enclave (2025) - 424,616 individuals, 212,313 matched reinfected/non-reinfected pairs - independently confirmed this, finding reinfection produced a roughly 35% higher incidence of Long Covid (risk ratio 1.35, 95% CI 1.32–1.39), with a cumulative incidence of 11.1% among reinfected versus 8.2% among non-reinfected individuals at one year. The authors explicitly note their result mirrors Bowe et al., the only prior large published study quantifying this effect. A community survey (medRxiv 2026) of 1,543 people found a clear dose–response: each subsequent infection increased the odds of reporting Long Covid by approximately 2-fold, and people who developed Long Covid after their first infection had a 3.2-fold higher risk of reporting symptoms again after a second infection (RR 3.23, 95% CI 2.52–4.13). The same survey found the risk of a second infection was 21% higher for people who had already developed Long Covid (RR 1.21, 95% CI 1.08–1.36) - suggesting Long Covid itself may increase susceptibility to reinfection.